Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuping Jiang

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
BMC Medical Research Methodology|October 28, 2025
A bayesian dynamic borrowing framework for improving the efficiency of clinical trialsZengyue Zheng, Keer Chen, Pengfei Zhu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 20, 2018
Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling PathwayJinhui Ye, Na Zhu, Ruipu Sun, et al.
Statistical Methods in Medical Research|February 6, 2026
A hybrid prior Bayesian method for combining domestic real-world data and overseas data in global drug developmentKeer Chen, Zengyue Zheng, Pengfei Zhu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2018
Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed WomenSally Hodder, Kathleen Squires, Cissy Kityo, et al.
European Journal of Medical Research|July 22, 2025
Anatomic-size determinants drive therapeutic decisions in inflammatory fibroid polyps: a retrospective studyXintong Chi, Jiexin Zhao, Jiaxin Shen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
The Lancet. HIV|August 27, 2016
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 studyKathleen Squires, Cissy Kityo, Sally Hodder, et al.
Journal of Patient-Reported Outcomes|April 11, 2026
Missing data considerations for patient reported outcome measures in randomized controlled trialsFan Wang, Shenran Deng, Jing Sun, et al.
Cell Death and Differentiation|June 2, 2026
LGALS1-CD276 Paracrine axis between tumor and endothelial cells promotes tumor angiogenesis and progression in bladder cancerZheng Liu, Zhipeng Yao, Yaxin Hou, et al.
American Journal of Cancer Research|December 23, 2015
MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expressionDaojiang Li, Zhengrong Li, Jianbo Xiong, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
BMC Medical Research Methodology|October 28, 2025
A bayesian dynamic borrowing framework for improving the efficiency of clinical trialsZengyue Zheng, Keer Chen, Pengfei Zhu, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 20, 2018
Metformin Inhibits Chemokine Expression Through the AMPK/NF-κB Signaling PathwayJinhui Ye, Na Zhu, Ruipu Sun, et al.
Statistical Methods in Medical Research|February 6, 2026
A hybrid prior Bayesian method for combining domestic real-world data and overseas data in global drug developmentKeer Chen, Zengyue Zheng, Pengfei Zhu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2018
Brief Report: Efficacy and Safety of Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (E/C/F/TAF) in Virologically Suppressed WomenSally Hodder, Kathleen Squires, Cissy Kityo, et al.
European Journal of Medical Research|July 22, 2025
Anatomic-size determinants drive therapeutic decisions in inflammatory fibroid polyps: a retrospective studyXintong Chi, Jiexin Zhao, Jiaxin Shen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2016
Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 StudyFrank A Post, Pablo Tebas, Amanda Clarke, et al.
The Lancet. HIV|August 27, 2016
Integrase inhibitor versus protease inhibitor based regimen for HIV-1 infected women (WAVES): a randomised, controlled, double-blind, phase 3 studyKathleen Squires, Cissy Kityo, Sally Hodder, et al.
Journal of Patient-Reported Outcomes|April 11, 2026
Missing data considerations for patient reported outcome measures in randomized controlled trialsFan Wang, Shenran Deng, Jing Sun, et al.
Cell Death and Differentiation|June 2, 2026
LGALS1-CD276 Paracrine axis between tumor and endothelial cells promotes tumor angiogenesis and progression in bladder cancerZheng Liu, Zhipeng Yao, Yaxin Hou, et al.
American Journal of Cancer Research|December 23, 2015
MicroRNA-212 functions as an epigenetic-silenced tumor suppressor involving in tumor metastasis and invasion of gastric cancer through down-regulating PXN expressionDaojiang Li, Zhengrong Li, Jianbo Xiong, et al.
Pageof 3